| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $3,358,233 ) |
| | 2026 | 2026 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01AI104987 | Beta-Lactam Resistance Mechanisms of Staphylococcus aureus | 000 | 14 | NIH | 1/29/2026 | $630,355 |
| | 2026 | 2026 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01CA270147 | Engineering the Next Generation of Safer Hsp90 Inhibitors | 000 | 4 | NIH | 1/12/2026 | $408,431 |
| | 2026 | 2026 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01AG091375 | A macrocyclic peptide platform for the discovery of functional tau epitopes | 000 | 2 | NIH | 12/16/2025 | $543,357 |
| | 2026 | 2026 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01EY034493 | Elucidating and bypassing molecular mechanisms that suppress Muller glia-dependent regeneration of cones in two zebrafish models of chronic retinal damage | 000 | 4 | NIH | 1/27/2026 | $555,742 |
| | 2026 | 2026 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R00NS133484 | Immune regulation of spinal cord regeneration | 000 | 3 | NIH | 2/6/2026 | $224,100 |
| | 2026 | 2026 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R35GM156615 | Regulation and function of multicellular calcium signaling in organ growth and regeneration | 000 | 2 | NIH | 1/22/2026 | $396,268 |
| | 2026 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01DK128805 | Understanding the role of catheter-associated protein deposition in the development of CAUTI | 000 | 5 | NIH | 12/9/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R21AI180663 | Deciphering P. falciparum artemisinin resistance in Bangladesh: a genotypic-phenotypic evaluation of Kelch13 dependent and independent determinants | 000 | 2 | NIH | 1/16/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01AG071684 | A life course perspective on gut microbiome aging and health in a non-human primate model | 000 | 5 | NIH | 11/6/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01AI155723 | Carbapenemase-Stable Carbapenem Antibiotics for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections | 000 | 5 | NIH | 12/31/2025 | $0 |
| | 2026 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | H79SM089894 | ND Cares | 001 | 2 | SAMHSA | 1/15/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | H79SM089894 | ND Cares | 000 | 2 | SAMHSA | 1/14/2026 | $0 |
| | 2026 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | H79SM090642 | Northwest Indiana Identification and Management of Pediatric Experiences of Trauma and Underlying Stress (NWI IMPETUS) | 000 | 3 | SAMHSA | 12/19/2025 | $599,990 |
| | 2026 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01MH124958 | Effectiveness of an Empirically Supported Family Intervention: Mental Health Outcomes, Mechanisms of Effect, and Organizational Factors | 000 | 4 | NIH | 12/11/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01HL177814 | SCH: Efficient Image-based Hemodynamic Modeling via Physics-integrated Bayesian Deep Learning | 001 | 1 | NIH | 1/20/2026 | -$51,532 |
| | 2026 | 2024 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01HL177814 | SCH: Efficient Image-based Hemodynamic Modeling via Physics-integrated Bayesian Deep Learning | 001 | 1 | NIH | 1/20/2026 | $145,752 |
| | 2026 | 2024 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01HL177814 | SCH: Efficient Image-based Hemodynamic Modeling via Physics-integrated Bayesian Deep Learning | 000 | 1 | NIH | 1/20/2026 | $51,532 |
| | 2026 | 2024 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01AI178776 | Spore germination pathway in Clostridioides difficile and its pharmacological intervention | 000 | 1 | NIH | 11/21/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01AI167284 | Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants | 000 | 3 | NIH | 2/5/2026 | $0 |
| | 2026 | 2024 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01AI148217 | Bulgecin Template for Potentiation of beta-Lactam Antibiotics | 000 | 5 | NIH | 12/31/2025 | $0 |
| | 2026 | 2024 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01MH133226 | Leveraging Noninvasive Transcutaneous Vagus Nerve Stimulation and Smartphone Technology to Reduce Suicidal Behaviors and Suicide Among Highly Vulnerable Adolescents | 000 | 3 | NIH | 1/26/2026 | $0 |
| | 2026 | 2024 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01HL177814 | SCH: Efficient Image-based Hemodynamic Modeling via Physics-integrated Bayesian Deep Learning | 000 | 1 | NIH | 1/20/2026 | -$145,752 |
| | 2026 | 2023 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R03CA273469 | New approaches to study tumor microvesicles | 000 | 2 | NIH | 12/16/2025 | -$10 |
| | 2026 | 2022 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R56HL013423 | Plasminogen and Plasmin: Structure and Function | 001 | 47 | NIH | 12/19/2025 | -$60,183 |
| | 2026 | 2022 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R56HL013423 | Plasminogen and Plasmin: Structure and Function | 000 | 47 | NIH | 12/19/2025 | $60,183 |
|
| Issue Date FY: 2025 ( Subtotal = $29,985,841 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | T32GM145773 | Chemistry-Biochemistry-Biology Interface (CBBI) Program at Notre Dame | 000 | 4 | NIH | 6/6/2025 | $321,270 |
| | 2025 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01AI167284 | Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants | 001 | 4 | NIH | 8/12/2025 | $1,447,329 |
| | 2025 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01CA280097 | Immunosuppression and Metabolic Rewiring in Tumor-infiltrating Neutrophils | 001 | 3 | NIH | 5/22/2025 | $36,219 |
| | 2025 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01CA280097 | Immunosuppression and Metabolic Rewiring in Tumor-infiltrating Neutrophils | 000 | 3 | NIH | 4/25/2025 | $325,977 |
| | 2025 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01NS135852 | CRCNS: Defining the role of astrogenesis in cortical folding | 001 | 3 | NIH | 8/6/2025 | $14,429 |
| | 2025 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01NS135852 | CRCNS: Defining the role of astrogenesis in cortical folding | 000 | 3 | NIH | 7/28/2025 | $129,858 |
| | 2025 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01GM148708 | New insights into extracellular signal transduction | 000 | 3 | NIH | 7/23/2025 | $328,650 |
| | 2025 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01MH128929 | An evidence-based family support program for parents and children: A theory-based intervention | 000 | 4 | NIH | 9/9/2025 | $639,084 |
| | 2025 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01AG071684 | A life course perspective on gut microbiome aging and health in a non-human primate model | 001 | 5 | NIH | 8/21/2025 | $49,959 |
| | 2025 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01AG071684 | A life course perspective on gut microbiome aging and health in a non-human primate model | 000 | 5 | NIH | 1/13/2025 | $562,056 |
| | 2025 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01CA252878 | CXCL5/CXCR2 axis as a therapeutic vulnerability of breast cancer metastasis to bone | 000 | 5 | NIH | 5/12/2025 | $357,994 |
| | 2025 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01CA267978 | 3H-pyrazolo[4,3-f]quinoline-containing compounds as selective and tunable protein kinase inhibitors | 001 | 4 | NIH | 6/19/2025 | $461,983 |
| | 2025 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | K23MH131753 | Neurobehavioral markers of positive valence systems in mothers with depression and young offspring | 003 | 4 | NIH | 8/11/2025 | $187,219 |
| | 2025 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R35GM143029 | Model-based inference and forecasting of co-circulating pathogen dynamics | 000 | 5 | NIH | 9/9/2025 | $391,250 |
| | 2025 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | DP1GM146256 | Decoding the regulation of protein folding by synonymous codon usage | 000 | 5 | NIH | 7/24/2025 | $1,095,500 |
| | 2025 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01AI155723 | Carbapenemase-Stable Carbapenem Antibiotics for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections | 000 | 5 | NIH | 3/19/2025 | $773,298 |
| | 2025 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | K23AA029729 | Developing a modified brief alcohol-focused intervention tailored for patients with alcohol use disorder in opioid agonist treatment | 000 | 5 | NIH | 4/24/2025 | $153,820 |
| | 2025 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01CA262439 | Mitophagy-Mediated Cell Death in Mammary Tumorigenesis | 002 | 5 | NIH | 9/2/2025 | $73,042 |
| | 2025 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01CA262439 | Mitophagy-Mediated Cell Death in Mammary Tumorigenesis | 001 | 5 | NIH | 8/29/2025 | $398,607 |
| | 2025 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | F32HL165966 | Investigating the Critical Role of Glia In Peripheral Organ Development and Physiology | 000 | 3 | NIH | 5/16/2025 | $78,892 |
| | 2025 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | F32HL165966 | Investigating the Critical Role of Glia In Peripheral Organ Development and Physiology | 001 | 3 | NIH | 8/21/2025 | $1,332 |
| | 2025 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R35GM143055 | Engineering the Stem Cell Microenvironment for Lymphatic Regeneration | 000 | 5 | NIH | 5/13/2025 | $391,250 |
| | 2025 | 2025 | UNIVERSITY OF NOTRE DAME DU LAC | 940 GRACE HALL | NOTRE DAME | IN | 46556-5708 | ST JOSEPH | USA | R01AG074570 | Chemical approaches to selectively target beta-rich amyloids | 001 | 5 | NIH | 6/5/2025 | $471,616 |
|
